KBC Group
PBYI icon

KBC Group’s Puma Biotechnology PBYI Stock Holding History

KBC Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,735
Closed -$48K – 1308
2020
Q1 		$48K Hold
5,735
– – ﹤0.01% 1203
2019
Q4 		$50K Hold
5,735
– – ﹤0.01% 1409
2019
Q3 		$62K Buy
+5,735
New +$61.9K ﹤0.01% 1374
2015
Q4 		– Sell
-942
Closed -$71K – 1312
2015
Q3 		$71K Hold
942
– – ﹤0.01% 1177
2015
Q2 		$110K Buy
+942
New +$171K ﹤0.01% 1239

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

KBC Group's PBYI Position: Q2 2020 in Review

KBC Group sold out of Puma Biotechnology (PBYI) in Q2 2020, closing a stake of 5,735 shares — an estimated $48K sold.

KBC Group first reported a position in PBYI in Q2 2015 and held it in 5 quarters. The position peaked at $110K in Q2 2015. 128 funds tracked by Wall St. Rank hold PBYI as of Q2 2020.

  • KBC Group reported no remaining Puma Biotechnology position as of Q2 2020 after selling out during the quarter.
  • KBC Group sold 5,735 Puma Biotechnology shares in Q2 2020, an estimated $48K.
  • KBC Group first reported a position in Puma Biotechnology in Q2 2015 and held it in 5 quarters.
  • KBC Group's Puma Biotechnology position peaked at $110K in Q2 2015.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2020.

Based on KBC Group's 13F filing for Q2 2020, filed 10 Aug 2020.